P2X7 receptors (P2X7R) are ligand-gated ion channels activated by adenosine 5’-triphosphate (ATP), which are involved in processes that are dysfunctional in stress response and depression, such as neurotransmitter release, and neuroimmune response. Genetic and pharmacological inhibition of the P2X7R induce antidepressant-like effects in animals exposed to stress. However, the effect of P2X7R antagonism in an animal model of depression based on selective breeding has not previously been studied, and the mechanism underling the antidepressant-like effect induced by the P2X7R blockade remains unknown.
Aims:
The present study aimed to: (1) determine whether P2X7R blockade induces antidepressant-like effects in the Flinders Sensitive Line (FSL) rats and, (2) investigate whether brain-derived neurotrophic factor (BDNF) signalling in the frontal cortex and hippocampus is involved in this effect.
Methods:
FSL and the control Flinders Resistant Line (FRL) rats were treated with vehicle or the P2X7R antagonist A-804598 (3, 10 or 30 mg/Kg/day) for 1 or 7 days before being exposed to the forced swim test (FST). After the behavioural test, animals were decapitated, their brains were removed and the frontal cortex, ventral and dorsal hippocampus were dissected for BDNF signalling analysis.
Results:
We found that repeated treatment with A-804598 (30 mg/Kg) reduced the immobility time in the FST and activated the BDNF signalling in the ventral hippocampus of FSL rats.
Conclusions:
P2X7R blockade induces an antidepressant-like effect associated with increased levels of BDNF-AKT-p70 S6 kinase in the ventral hippocampus, which may be mediated by tropomyosin-related kinase B (TRKB) receptor activation supporting the notion of P2X7R antagonism as a potential new antidepressant strategy.
AdinolfiEGiulianiALDe MarchiE, et al. (2018) The P2X7 receptor: A main player in inflammation. Biochem Pharmacol151: 234–244.
2.
AlessiDRKozlowskiMTWengQP, et al. (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol8: 69–81.
3.
AnjumRBlenisJ (2008) The RSK family of kinases: Emerging roles in cellular signalling. Nat Rev Mol Cell Biol9: 747–758.
4.
ArdalanMWegenerGRafatiAH, et al. (2017) S-ketamine rapidly reverses synaptic and vascular deficits of hippocampus in genetic animal model of depression. Int J Neuropsychopharmacol20: 247–256.
5.
BassoAMBratcherNAHarrisRR, et al. (2009) Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders. Behav Brain Res198: 83–90.
6.
BennettMRFarnellLGibsonWG (2009) P2X7 regenerative-loop potentiation of glutamate synaptic transmission by microglia and astrocytes. J Theor Biol261: 1–16.
7.
BermanRMCappielloAAnandA, et al. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry47: 351–354.
8.
BhattacharyaAJonesDNC (2018) Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders. Psychoneuroendocrinology98: 95–100.
9.
BoucherAAArnoldJCHuntGE, et al. (2011) Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test. Neuroscience189: 170–177.
10.
CaanW (2015) The global crisis of depression: The low of the 21st century?Perspect Public Health135: 62.
11.
CastrénERantamäkiT (2010) The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol70: 289–297.
12.
CastrénEVõikarVRantamäkiT (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol7: 18–21.
13.
CatanzaroJMHuestonCMDeakMM, et al. (2014) The impact of the P2X7 receptor antagonist A-804598 on neuroimmune and behavioral consequences of stress. Behav Pharmacol25: 582–598.
14.
ChenBDowlatshahiDMacQueenGM, et al. (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry50: 260–265.
15.
ChisholmDSweenyKSheehanP, et al. (2016) Scaling-up treatment of depression and anxiety: A global return on investment analysis. Lancet Psychiatry3: 415–424.
16.
CiprianiAFurukawaTASalantiG, et al. (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet373: 746–758.
17.
CiprianiAFurukawaTASalantiG, et al. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet391: 1357–1366.
18.
CoppellALPeiQZetterströmTS (2003) Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology44: 903–910.
19.
Costa-MattioliMMonteggiaLM (2013) mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci16: 1537–1543.
20.
CryanJFMombereauCVassoutA (2005) The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev29: 571–625.
21.
CsölleCAndóRDKittelÁ, et al. (2013a) The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice. Int J Neuropsychopharmacol16: 213–233.
22.
CsölleCBaranyiMZsillaG, et al. (2013b) Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors. PLoS One8: e66547.
23.
CunhaCBrambillaRThomasKL (2010) A simple role for BDNF in learning and memory?Front Mol Neurosci3: 1.
24.
Di VirgilioFDal BenDSartiAC, et al. (2017) The P2X7 receptor in infection and inflammation. Immunity47: 15–31.
25.
DinizCRodriguesMCasarottoPC, et al. (2017) Monoamine involvement in the antidepressant-like effect induced by P2 blockade. Brain Res1676: 19–27.
26.
Donnelly-RobertsDLNamovicMTHanP, et al. (2009a) Mammalian P2X7 receptor pharmacology: Comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol157: 1203–1214.
27.
Donnelly-RobertsDLNamovicMTSurberB, et al. (2009b) [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharmacology56: 223–229.
28.
du JardinKGLiebenbergNCajinaM, et al. (2018) S-Ketamine mediates its acute and sustained antidepressant-like activity through a 5-HT1B receptor dependent mechanism in a genetic rat model of depression. Front Pharmacol8: 978.
29.
DumanRSHeningerGRNestlerEJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry54: 597–606.
30.
DumanRSMonteggiaLM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry59: 1116–1127.
31.
DumanRSVoletiB (2012) Signaling pathways underlying the pathophysiology and treatment of depression: Novel mechanisms for rapid-acting agents. Trends Neurosci35: 47–56.
32.
DwivediYRizaviHSConleyRR, et al. (2006) ERK MAP kinase signaling in post-mortem brain of suicide subjects: Differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry11: 86–98.
33.
DwivediYRizaviHSRobertsRC, et al. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem77: 916–928.
34.
ElfvingBPlougmannPHMüllerHK, et al. (2010) Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol13: 563–572.
35.
FerrariAJCharlsonFJNormanRE, et al. (2013) The epidemiological modelling of major depressive disorder: Application for the global burden of disease study 2010. PLoS One8: e69637.
36.
GreenbaumDColangeloCWilliamsK, et al. (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol4: 117.
37.
HarmerCJDumanRSCowenPJ (2017) How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry4: 409–418.
38.
IllesPKhanTMRubiniP (2017) Neuronal P2X7 receptors revisited: Do they really exist?J Neurosci37: 7049–7062.
39.
IwataMOtaKTLiXY, et al. (2016) Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol Psychiatry80: 12–22.
40.
JefsenOHøjgaardKChristiansenSL, et al. (2019) Psilocybin lacks antidepressant-like effect in the flinders sensitive line rat. Acta Neuropsychiatrica31: 213–219.
41.
Jimenez-MateosEMSmithJNickeA, et al. (2019) Regulation of P2X7 receptor expression and function in the brain. Brain Research Bulletin. (In Press)
42.
LiebenbergNJocaSWegenerG (2015) Nitric oxide involvement in the antidepressant-like effect of ketamine in the flinders sensitive line rat model of depression. Acta Neuropsychiatr27: 90–96.
43.
LindbergDShanDAyers-RinglerJ, et al. (2015) Purinergic signaling and energy homeostasis in psychiatric disorders. Curr Mol Med15: 275–295.
44.
LiuYBeyerAAebersoldR (2016) On the dependency of cellular protein levels on mrna abundance. Cell165: 535–550.
45.
MaMRenQZhangJC, et al. (2014) Effects of brilliant blue g on serum tumor necrosis factor-α levels and depression-like behavior in mice after lipopolysaccharide administration. Clin Psychopharmacol Neurosci12: 31–36.
46.
Machado-VieiraRBaumannJWheeler-CastilloC, et al. (2010) The timing of antidepressant effects: A comparison of diverse pharmacological and somatic treatments. Pharmaceuticals (Basel)3: 19–41.
47.
MartinowichKLuB (2008) Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacology33: 73–83.
48.
MartinowichKManjiHLuB (2007) New insights into BDNF function in depression and anxiety. Nat Neurosci10: 1089–1093.
49.
MayhewJGrahamBABiberK, et al. (2018) Purinergic modulation of glutamate transmission: An expanding role in stress-linked neuropathology. Neurosci Biobehav Rev93: 26–37.
50.
McManusJChengZVogelC (2015) Next-generation analysis of gene expression regulation–comparing the roles of synthesis and degradation. Mol Biosyst11: 2680–2689.
51.
MetzgerMWWalserSMAprile-GarciaF, et al. (2017) Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice. Purinergic Signal13: 153–170.
52.
Miras-PortugalMTSebastián-SerranoÁde Diego GarcíaL, et al. (2017) Neuronal P2X7 receptor: Involvement in neuronal physiology and pathology. J Neurosci37: 7063–7072.
53.
MolteniRCalabreseFBedogniF, et al. (2006) Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions. Int J Neuropsychopharmacol9: 307–317.
54.
MüllerHKWegenerGPopoliM, et al. (2011) Differential expression of synaptic proteins after chronic restraint stress in rat prefrontal cortex and hippocampus. Brain Res1385: 26–37.
55.
NavaNTreccaniGMüllerHK, et al. (2017) The expression of plasticity-related genes in an acute model of stress is modulated by chronic desipramine in a time-dependent manner within medial prefrontal cortex. Eur Neuropsychopharmacol27: 19–28.
56.
NibuyaMMorinobuSDumanRS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci15: 7539–7547.
57.
OverstreetDHHlavkaJFeighnerJP, et al. (2004) Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression. Psychopharmacology (Berl)175: 303–309.
58.
OverstreetDHPucilowskiORezvaniAH, et al. (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of flinders sensitive line rats as an animal model of depression. Psychopharmacology (Berl)121: 27–37.
59.
OverstreetDHWegenerG (2013) The flinders sensitive line rat model of depression–25 years and still producing. Pharmacol Rev65: 143–155.
60.
PereiraVSCasarottoPCHiroaki-SatoVA, et al. (2013) Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxide. Eur Neuropsychopharmacol23: 1769–1778.
61.
PereiraVSJocaSRLHarveyBH, et al. (2019a) Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression. Acta Neuropsychiatrica24: 1–23.
PorsoltRDAntonGBlavetN, et al. (1978) Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol47: 379–391.
64.
PucilowskiOOverstreetDH (1993) Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains. Brain Res Bull32: 471–475.
65.
PullenNDennisPBAndjelkovicM, et al. (1998) Phosphorylation and activation of p70s6k by PDK1. Science279: 707–710.
66.
RantamäkiTHendolinPKankaanpääA, et al. (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology32: 2152–2162.
SaarelainenTHendolinPLucasG, et al. (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci23: 349–357.
69.
SaitohMPullenNBrennanP, et al. (2002) Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem277: 20104–20112.
70.
SantarelliLSaxeMGrossC, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science301: 805–809.
71.
SchillerGDPucilowskiOWienickeC, et al. (1992) Immobility-reducing effects of antidepressants in a genetic animal model of depression. Brain Res Bull28: 821–823.
72.
SimJA (2004) Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci24: 6307–6314.
73.
SluyterR (2017) The P2X7 receptor. Adv Exp Med Biol1051: 17–53.
74.
SperlághBIllesP (2014) P2X7 receptor: An emerging target in central nervous system diseases. Trends Pharmacol Sci35: 537–547.
75.
SperlághBKöfalviADeucharsJ, et al. (2002) Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem81: 1196–1211.
76.
WethmarKSminkJJLeutzA (2010) Upstream open reading frames: Molecular switches in (patho)physiology. BioEssays32: 885–893.
77.
Yankelevitch-YahavRFrankoMHulyA, et al. (2015) The forced swim test as a model of depressive-like behavior. J Vis Exp97: e52587.
78.
ZangenANakashROverstreetDH, et al. (2001) Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology (Berl)155: 434–439.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
